Unlocking the Mysteries of the Human Microbiome to Combat COVID-19

The recent global dissemination of the novel coronavirus SARS-CoV-2 and the subsequent COVID-19 pandemic have galvanized the scientific community around the central goal of developing therapeutics for immediate and long-term treatment. Based on this study, it can be inferred that the human microbiome can have a profound impact on susceptibility to SARS-CoV-2 infection and COVID-19 severity. The involvement of gastrointestinal symptoms and respiratory illness in COVID-19 makes the gut and lung microbiota a potential target in COVID-19 management